Searchable abstracts of presentations at key conferences in endocrinology

ea0095oc9.2 | Oral Communications 9 | BSPED2023

Screening for paediatric type 1 diabetes – A qualitative study of parents and stakeholders

Sai Manas Setti Naga , Quinn Lauren , Horgan Thomas , Dias Renuka , Garstang Joana , Shukla David , Greenfield Sheila , Richter Alex , Narendran Parth

Objective: The EarLy Surveillance for Autoimmune diabetes (ELSA) study is screening 20,000 children aged 3-13 years for type 1 diabetes through measurement of islet autoantibodies. Screening aims to prevent diabetic ketoacidosis at clinical onset of disease and identifies the population who could benefit from prevention trials. The ELSA-1 study aimed to explore the perspectives of parents and stakeholders on the relative benefits and limitations of screening i...

ea0094p58 | Metabolism, Obesity and Diabetes | SFEBES2023

EarLy Surveillance for Autoimmune type 1 diabetes (ELSA) – paediatric, general population screening in the UK

Marie Quinn Lauren , Dias Renuka , Rashid Rajeeb , Garstang Joanna , Shukla David , Margaret Greenfield Sheila , Richter Alex , Narendran Parth , Shu Huang Low Brandon

Background: Children with pre-symptomatic type 1 diabetes (T1D) can be identified through testing for circulating islet autoantibodies (AAb). Identifying children at risk reduces diabetic ketoacidosis at onset and allows participation in trials aiming for immunoprevention. The EarLy Surveillance for Autoimmune diabetes (ELSA) study is exploring feasibility and acceptability of UK paediatric general population screening.Methods:</...